TRIENTINE WAYMADE (Waymade Australia Pty Limited)
Product name
TRIENTINE WAYMADE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
188 (255 working days)
Active ingredients
trientine dihydrochloride
Registration type
NCE/NBE
Indication
TRIENTINE WAYMADE (capsule) is indicated in the treatment of patients with Wilson's disease who are intolerant of penicillamine.
Registration process
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.